These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12400766)

  • 1. Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery.
    Fellinger EK; Leavitt BJ; Hebert JC
    Ann Thorac Surg; 2002 Oct; 74(4):1187-90. PubMed ID: 12400766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.
    Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefazolin concentrations in serum during cardiopulmonary bypass surgery.
    Miglioli PA; Merlo F; Calabrò GB; Allerberger F; Fille M
    Drugs Exp Clin Res; 2005; 31(1):29-33. PubMed ID: 15921027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery.
    Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M
    Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass.
    Calic D; Ariano RE; Arora RC; Grocott HP; Lakowski TM; Lillico R; Zelenitsky SA
    J Antimicrob Chemother; 2018 Mar; 73(3):768-771. PubMed ID: 29237016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Intraoperative Continuous-Infusion Versus Intermittent Dosing of Cefazolin Therapy on the Incidence of Surgical Site Infections After Coronary Artery Bypass Grafting.
    Shoulders BR; Crow JR; Davis SL; Whitman GJ; Gavin M; Lester L; Barodka V; Dzintars K
    Pharmacotherapy; 2016 Feb; 36(2):166-73. PubMed ID: 26799442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study to determine the feasibility of continuous cefazolin infusion.
    Waltrip T; Lewis R; Young V; Farmer M; Clayton S; Myers S; Gray LA; Galandiuk S
    Surg Infect (Larchmt); 2002; 3(1):5-9. PubMed ID: 12593694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.
    De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P
    J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants.
    Himebauch AS; Nicolson SC; Sisko M; Moorthy G; Fuller S; Gaynor JW; Zuppa AF; Fox E; Kilbaugh TJ
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2634-41. PubMed ID: 25131168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefazolin delivery via the cardiopulmonary bypass circuit priming solution in infants and children.
    Cies JJ; Moore WS; Parker J; Stevens R; Al-Qaqaa Y; Enache A; Chopra A
    J Antimicrob Chemother; 2019 May; 74(5):1342-1347. PubMed ID: 30689931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cefazolin levels during cardiovascular surgery: effects of cardiopulmonary bypass and profound hypothermic circulatory arrest.
    Caffarelli AD; Holden JP; Baron EJ; Lemmens HJ; D'Souza H; Yau V; Olcott C; Reitz BA; Miller DC; van der Starre PJ
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1338-43. PubMed ID: 16733167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Cefazolin and Vancomycin in Infants Undergoing Open-Heart Surgery With Cardiopulmonary Bypass.
    Ingrande J; Gutierrez K; Lemmens HJ; Verma A; Nicolau DP; Sutherland CA; Ramamoorthy C
    Anesth Analg; 2019 May; 128(5):935-943. PubMed ID: 30995208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of cefazolin in pediatric patients undergoing cardiac surgery.
    Lapmahapaisan S; Maisat W; Tantiwongkosri K; Jutasompakorn P; Sisan W
    Ann Card Anaesth; 2021; 24(2):149-154. PubMed ID: 33884969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cardiopulmonary bypass on the disposition of cefazolin in patients undergoing cardiothoracic surgery.
    Asada M; Nagata M; Mizuno T; Uchida T; Kurashima N; Takahashi H; Makita K; Arai H; Echizen H; Yasuhara M
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00440. PubMed ID: 30410768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a Dosing Strategy for Cefazolin for Surgery Requiring Cardiopulmonary Bypass.
    Hollis AL; Heil EL; Nicolau DP; Odonkor P; Dowling TC; Thom KA
    Surg Infect (Larchmt); 2015 Dec; 16(6):829-32. PubMed ID: 26291478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefazolin and netilmicin serum levels during and after cardiac surgery with cardiopulmonary bypass.
    Lehot JJ; Reverdy ME; Etienne J; Corot C; Nervi C; Sear J; Fleurette J; Estanove S
    J Cardiothorac Anesth; 1990 Apr; 4(2):204-9. PubMed ID: 2131868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cefazolin levels during cardiopulmonary bypass.
    Akl BF; Richardson G
    Ann Thorac Surg; 1980 Feb; 29(2):109-12. PubMed ID: 7356361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing.
    Chen X; Brathwaite CE; Barkan A; Hall K; Chu G; Cherasard P; Wang S; Nicolau DP; Islam S; Cunha BA
    Obes Surg; 2017 Mar; 27(3):626-629. PubMed ID: 27520693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
    Andreas M; Zeitlinger M; Wisser W; Jaeger W; Maier-Salamon A; Thalhammer F; Kocher A; Hiesmayr JM; Laufer G; Hutschala D
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):758-64. PubMed ID: 25527166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid.
    Eley VA; Christensen R; Ryan R; Jackson D; Parker SL; Smith M; van Zundert AA; Wallis SC; Lipman J; Roberts JA
    Anesth Analg; 2020 Jul; 131(1):199-207. PubMed ID: 32250982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.